Pei Wang
Senior Vice President, Clinical Development & CMC Eureka Therapeutics
Dr. Wang is Senior Vice President of Clinical Development and CMC at Eureka Therapeutics and has over 17 years of experience advancing T-cell therapies from early research through clinical development. At Eureka, she directs clinical development and manufacturing strategy across multiple programs and serves as Principal Investigator for the California Institute for Regenerative Medicine (CIRM)-funded ARYA-2 pediatric cancer initiative. Her work has advanced programs earning FDA Fast Track, Rare Disease, Orphan Drug and Regenerative Medicine Advanced Therapy designations and driven successful IND submissions and strategic collaborations with academic institutions and industrial partners. Dr. Wang earned a Ph.D. from The University of Texas at Austin and a B.S. from Peking University.
